Literature DB >> 18691663

Paradigm shifts in the cell biology of STAT signaling.

Pravin B Sehgal1.   

Abstract

In recent years several of the key tenets of the original cytokine-STAT-signaling paradigm had to be revised. First, the notion that nonphosphorylated "inactive" STATs are present in the cytoplasm as free monomers which dimerized only subsequent to Tyr-phosphorylation has been replaced by the understanding that nonphosphorylated STATs in the cytoplasm exist largely as dimers and high molecular mass "statosome" complexes. Second, the notion that phosphorylation, either of Tyr or Ser residues or both, in STAT species is required for transcriptional activation has been replaced by the realization that nonphosphorylated STATs can be transcriptionally active albeit with respect to sets of target genes distinct from phosphorylated STATs. Third, the notion that it is the activation by phosphorylation of STATs at the plasma membrane that then leads to their import into the nucleus has been replaced by the recognition that even nonphosphorylated STATs shuttle between the cytoplasm and nucleus at all times in a constitutive manner. Fourth, the notion that the trans-cytoplasmic transit of STATs from the plasma membrane to the nuclear import machinery takes place exclusively as a free cytosolic process has been replaced by the understanding that at least a portion of this trans-cytoplasmic transit is mediated via membrane-associated caveolar and endocytic trafficking (the "signaling endosome" hypothesis). Fifth, the targeting and sequestration of activated STAT3 to long-lived endosomes in the cytoplasm requires consideration of STAT3-mediated "signal transduction" from the plasma membrane to cytoplasmic membrane destinations potentially for function(s) in the cytoplasm. Indeed, in tissue sections many discrete histologic cell types display PY-STAT3 almost exclusively in the cytoplasm with little, if any, in the nucleus. New challenges include determining the structural bases for the recruitment of nonphosphorylated dimeric STAT species to the cytosolic face of membranes including at the cytoplasmic tails of respective receptor complexes, the conformational changes subsequent to phosphorylation and the structural bases for the targeting and functions of STAT proteins within the cytoplasm per se.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691663      PMCID: PMC2597702          DOI: 10.1016/j.semcdb.2008.07.003

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  83 in total

1.  Real time analysis of STAT3 nucleocytoplasmic shuttling.

Authors:  Albert L Pranada; Silke Metz; Andreas Herrmann; Peter C Heinrich; Gerhard Müller-Newen
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

2.  STATs dimerize in the absence of phosphorylation.

Authors:  Jutta Braunstein; Siska Brutsaert; Rich Olson; Christian Schindler
Journal:  J Biol Chem       Date:  2003-06-28       Impact factor: 5.157

Review 3.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Authors:  Antje K Kretzschmar; Michaela C Dinger; Christian Henze; Katja Brocke-Heidrich; Friedemann Horn
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 5.  Plasma membrane rafts and chaperones in cytokine/STAT signaling.

Authors:  Pravin B Sehgal
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

Review 6.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

7.  N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation.

Authors:  Naruhisa Ota; Tom J Brett; Theresa L Murphy; Daved H Fremont; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-01-04       Impact factor: 25.606

8.  Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?

Authors:  Martina Schröder; Karen M Kroeger; Hans-Dieter Volk; Karin A Eidne; Gerald Grütz
Journal:  J Leukoc Biol       Date:  2004-01-23       Impact factor: 4.962

9.  Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion.

Authors:  Heather M Thompson; Hong Cao; Jing Chen; Ursula Euteneuer; Mark A McNiven
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

10.  Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility.

Authors:  Debra L Silver; Honami Naora; Jinsong Liu; Wenjun Cheng; Denise J Montell
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

View more
  65 in total

1.  Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cells.

Authors:  Carlos Zgheib; Fouad A Zouein; Rony Chidiac; Mazen Kurdi; George W Booz
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

Review 2.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

3.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

Review 4.  Targeting STAT3 in cancer: how successful are we?

Authors:  Peibin Yue; James Turkson
Journal:  Expert Opin Investig Drugs       Date:  2009-01       Impact factor: 6.206

5.  Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.

Authors:  Mukut Sharma; Jianping Zhou; Jean-François Gauchat; Ram Sharma; Ellen T McCarthy; Tarak Srivastava; Virginia J Savin
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

6.  STAT1 activation regulates proliferation and differentiation of renal progenitors.

Authors:  Honghe Wang; Yili Yang; Nirmala Sharma; Nadya I Tarasova; Olga A Timofeeva; Robin T Winkler-Pickett; Shunsuke Tanigawa; Alan O Perantoni
Journal:  Cell Signal       Date:  2010-07-17       Impact factor: 4.315

7.  Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.

Authors:  Nelson Ung; Tracy L Putoczki; Stanley S Stylli; Irvin Ng; John M Mariadason; Timothy A Chan; Hong-Jian Zhu; Rodney B Luwor
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

8.  Activation of Stat3 in renal tumors.

Authors:  Charles Guo; Guanyu Yang; Kyle Khun; Xiantian Kong; David Levy; Peng Lee; Jonathan Melamed
Journal:  Am J Transl Res       Date:  2009-02-28       Impact factor: 4.060

9.  A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.

Authors:  Shu-Chun Peng; Yen-Ting Lai; Hsi-Yuan Huang; Hsien-Da Huang; Yi-Shuian Huang
Journal:  Nucleic Acids Res       Date:  2010-07-17       Impact factor: 16.971

10.  Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAs.

Authors:  Jason E Lee; Yang-Ming Yang; Huijuan Yuan; Pravin B Sehgal
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-14       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.